This paper reports on the impact of 15 to 17 years of ivermectin treatment in two onchocerciasis foci in Kaduna State, Nigeria. In 2008, an epidemiological evaluation using the skin snip parasitological diagnostic method was undertaken in 26 villages and 3,703 people above the age of one year examined. The result was compared with the baseline survey undertaken in 1987.
Before treatment, the community prevalence of Onchocerca volvulus microfilaria in the skin ranged from 23.1% to 84.9%. After 15 to 17 years of treatment, the prevalence had fallen to 0% in all communities and all examined individuals were skin snip negative. The results of the surveys confirm an earlier finding from Senegal and Mali that ivermectin treatment alone can eliminate onchocerciasis infection and probably disease transmission in endemic foci in Africa.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.